CHARACTERIZATION OF STEREOISOMERISM OF ANTISENSE OLIGONUCLEOTIDES

被引:0
|
作者
TAMURA, Y
UEMATSU, H
MIYOSHI, H
MAKINO, K
MURAKAMI, A
机构
关键词
D O I
10.1246/nikkashi.1995.588
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Antisense strategy is one of the promising methods for curing incurable diseases such as cancer and AIDS by regulating gene expression. Oligonucleotides and their analogs have been innovated and used for the purposes. However, stereoisomerism of antisense molecules that intrinsically exists in such molecules contains a crucial problem for the future development of the strategy. In this report, the effects of stereoisomerism on antisense effects were studied by reversed phase HPLC, UV and CD spectroscopy. As antisense molecules, oligonucleoside phosphoramidates and oligonucleoside phosphorothioates both of which contain stereoisomeric modified phosphate linkages, were synthesized and characterized. As results, it was found that there exist large differences in solution structure and that the stereoisomerism may have crucial effect on the antisense gene regulation.
引用
收藏
页码:588 / 596
页数:9
相关论文
共 50 条
  • [41] Radiolabeled Oligonucleotides for Antisense Imaging
    Iyer, Arun K.
    He, Jiang
    CURRENT ORGANIC SYNTHESIS, 2011, 8 (04) : 604 - 614
  • [42] APPLICATIONS OF ANTISENSE OLIGONUCLEOTIDES IN ONCOLOGY
    PIERGA, JY
    MAGDELENAT, H
    CELLULAR AND MOLECULAR BIOLOGY, 1994, 40 (03) : 237 - 261
  • [43] Tissue pharmacokinetics of antisense oligonucleotides
    Baeckstroem, Erica
    Bonetti, Alessandro
    Johnsson, Per
    Oehlin, Stefan
    Dahlen, Anders
    Andersson, Patrik
    Andersson, Shalini
    Gennemark, Peter
    MOLECULAR THERAPY NUCLEIC ACIDS, 2024, 35 (01):
  • [44] LIPOSOMAL DELIVERY OF ANTISENSE OLIGONUCLEOTIDES
    THIERRY, AR
    DRITSCHILO, A
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1993, 6 (06): : 706 - 706
  • [45] Antisense oligonucleotides for atherosclerotic disease
    Archna Bajaj
    Daniel J. Rader
    Nature Medicine, 2020, 26 : 471 - 472
  • [46] Antisense Oligonucleotides Targeting Lipoprotein(a)
    Anne Langsted
    Børge G. Nordestgaard
    Current Atherosclerosis Reports, 2019, 21
  • [47] The concept and application of antisense oligonucleotides
    Yacyshyn, BR
    Crooke, ST
    DISEASES OF THE COLON & RECTUM, 2001, 44 (09) : 1241 - 1243
  • [48] Backbone modifications for antisense oligonucleotides
    DeMesmaeker, A
    Waldner, A
    Wendeborn, S
    Wolf, RM
    PURE AND APPLIED CHEMISTRY, 1997, 69 (03) : 437 - 440
  • [49] Mini-antisense oligonucleotides
    Pyshnyi, DV
    Pyshnaya, IA
    Lokhov, SG
    Ivanova, EM
    Zarytova, VF
    NUCLEOSIDES & NUCLEOTIDES, 1997, 16 (7-9): : 1565 - 1569
  • [50] Antisense oligonucleotides: The state of the art
    Aboul-Fadl, T
    CURRENT MEDICINAL CHEMISTRY, 2005, 12 (19) : 2193 - 2214